Real-world treatment patterns of palbociclib and blood count monitoring in patients with advanced breast cancer in Japan (vol 18, pg 2101, 2022)

被引：0
|
作者：
Sawaki, Masataka
Muramatsu, Yasuaki
Togo, Kanae
Laurent, Thomas
Iwata, Hiroji
机构：
来源：
FUTURE ONCOLOGY | 2023年
关键词：
D O I：
10.2217/fon-2021-1448c1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Demographic Characteristics and Treatment Patterns Among Patients Receiving Palbociclib for HR+/HER2-Advanced Breast Cancer: A Nationwide Real-World Experience
    Boer, Katalin
    Rubovszky, Gabor
    Rokszin, Gyorgy
    Abonyi-Toth, Zsolt
    Foldesi, Csenge
    Dank, Magdolna
    ONCOTARGETS AND THERAPY, 2021, 14 : 3971 - 3981
  • [12] REAL-WORLD TREATMENT PATTERNS AMONG PATIENTS WITH ADVANCED GASTRIC CANCER IN TAIWAN
    Gebra, Cuyun Carter
    Anna, Kaltenboeck
    Jasmina, Ivanova
    Astra, Liepa
    Alexandra, San Roman
    Maria, Koh
    Helen, Lee Hyun Jung
    Howard, Birnbaum
    Narayan, Rajan
    Shaila, Ballal
    Rebecca, Cheng
    Chen Jen-Shi
    ANNALS OF ONCOLOGY, 2014, 25 : 19 - 19
  • [13] Real-world dosing and CBC monitoring in patients with metastatic breast cancer during palbociclib plus letrozole therapy
    Kish, Jonathan
    Miller, Talia
    Nero, Damion
    Liassou, Djibril
    Liu, Xianchen
    McRoy, Lynn
    Feinberg, Bruce
    Zhan, Lin
    Trocio, Jeffrey
    CANCER RESEARCH, 2020, 80 (04)
  • [14] Efficacy and safety of palbociclib in treatment of HR-positive advanced breast cancer patients: A single center real-world experience.
    Vaid, Ashok K.
    Sharma, Devender
    Wadhwa, Jyoti
    Sharma, Nagender
    Mishra, Saurabh
    Gautam, Dheeraj
    Sen, Ashok
    Raju, Anisha
    Yadav, Lavina
    Verma, Girdhar
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [15] Real-world treatment of patients with palbociclib for HR+/HER2-advanced/metastatic breast cancer: the Europe IRIS study
    Mycock, Katie
    Zhan, Lin
    Hart, Kieran
    Taylor-Stokes, Gavin
    Milligan, Gary
    Atkinson, Christian
    Mitra, Debanjali
    FUTURE ONCOLOGY, 2021, 18 (03) : 349 - 362
  • [16] Real-world treatment patterns for palbociclib plus an aromatase inhibitor, or an aromatase inhibitor alone, for patients with metastatic breast cancer in the Flatiron Database
    Rugo, Hope S.
    Liu, Xianchen
    Li, Benjamin
    Mcroy, Lynn
    Chen, Connie
    Layman, Rachel M.
    Brufsky, Adam
    INTERNATIONAL JOURNAL OF CANCER, 2024, 154 (04) : 701 - 711
  • [17] Real-world treatment patterns and effectiveness of palbociclib plus an aromatase inhibitor in patients with metastatic breast cancer aged 75 years or older
    Brufsky, Adam
    Liu, Xianchen
    Li, Benjamin
    Mcroy, Lynn
    Chen, Connie
    Layman, Rachel M.
    Rugo, Hope S.
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [18] Real-world database analysis of the characteristics and treatment patterns of patients with endometrial cancer in Japan
    Akada, Keishi
    Koyama, Noriyuki
    Miura, Takuma
    Fukunaga, Eiji
    Miura, Yuji
    Aoshima, Ken
    Fujiwara, Keiichi
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (07) : 1171 - 1178
  • [19] REAL-WORLD SURVIVAL DATA OF PALBOCICLIB IN ADVANCED AND METASTATIC BREAST CANCER: A MULTICENTER EXPERIENCE IN LEBANON
    Nasr, Fadi
    Ghoche, Ahmad
    Diab, Saada
    Nasr, Lewis
    BREAST, 2019, 48 : S53 - S53
  • [20] Real-world treatment patterns and outcomes of abemaciclib for the treatment of HR +, HER2-metastatic breast cancer patients in Japan
    Nozawa, K.
    Terada, M.
    Onishi, M.
    Ozaki, Y.
    Takano, T.
    Fakhouri, W.
    Novick, D.
    Haro, J. M.
    Faris, L. H.
    Kawaguchi, T.
    Tanizawa, Y.
    Tsurutani, Junji
    BREAST CANCER, 2023, 30 (04) : 657 - 665
12345